Brian K. Rundall

556 total citations
12 papers, 475 citations indexed

About

Brian K. Rundall is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Brian K. Rundall has authored 12 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Brian K. Rundall's work include Histone Deacetylase Inhibitors Research (8 papers), NF-κB Signaling Pathways (7 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Brian K. Rundall is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), NF-κB Signaling Pathways (7 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Brian K. Rundall collaborates with scholars based in United States. Brian K. Rundall's co-authors include David R. Jones, Chadrick E. Denlinger, Michael D. Keller, Philip W. Smith, Yuan Liu, Mark E. Smolkin, Mark R. Wick, Thomas M. Daniel, Yuan Liu and Dylan Jones and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery.

In The Last Decade

Brian K. Rundall

12 papers receiving 465 citations

Peers

Countries citing papers authored by Brian K. Rundall

Since Specialization

Citations

This map shows the geographic impact of Brian K. Rundall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian K. Rundall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian K. Rundall more than expected).

Fields of papers citing papers by Brian K. Rundall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian K. Rundall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian K. Rundall. The network helps show where Brian K. Rundall may publish in the future.

Co-authorship network of co-authors of Brian K. Rundall

This figure shows the co-authorship network connecting the top 25 collaborators of Brian K. Rundall. A scholar is included among the top collaborators of Brian K. Rundall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian K. Rundall. Brian K. Rundall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Stage IB Nonsmall Cell Lung Cancers: Are They All the Same? 2006 ·The Annals of Thoracic Surgery ·David R. Jones, Thomas M. Daniel, Chadrick E. Denlinger, Brian K. Rundall, Mark E. Smolkin, Mark R. Wick	40
2	Suberoylanilide Hydroxamic Acid Induces Akt-mediated Phosphorylation of p300, Which Promotes Acetylation and Transcriptional Activation of RelA/p65 2006 ·Journal of Biological Chemistry ·Yuan Liu, Chadrick E. Denlinger, Brian K. Rundall, Philip W. Smith, David R. Jones	68
3	Suberoylanilide Hydroxamic Acid Induces Akt-mediated Phosphorylation of p300, Which Promotes Acetylation and Transcriptional Activation of RelA/p65 2006 ·Journal of Biological Chemistry ·Yuan Liu, Chadrick E. Denlinger, Brian K. Rundall, Philip W. Smith, David R. Jones	22
4	Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non–small cell lung cancer in vitro and in vivo 2005 ·Journal of Thoracic and Cardiovascular Surgery ·Chadrick E. Denlinger, Brian K. Rundall, David R. Jones	32
5	Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non–small cell lung cancer 2005 ·Surgery ·Brian K. Rundall, Chadrick E. Denlinger, David R. Jones	43
6	Laparoscopic Gastric Bypass Complicated by Gastric Pouch Necrosis: Considerations in Gastroesophageal Reconstruction 2005 ·Journal of Gastrointestinal Surgery ·Brian K. Rundall, Chadrick E. Denlinger, (unknown), Eugene F. Foley, David R. Jones	2
7	Proteasome inhibition sensitizes non–small cell lung cancer to histone deacetylase inhibitor–induced apoptosis through the generation of reactive oxygen species 2004 ·Journal of Thoracic and Cardiovascular Surgery ·Chadrick E. Denlinger, Brian K. Rundall, David R. Jones	56
8	Proteasome inhibition sensitizes non–small cell lung cancer to histone deacetylase inhibitor–induced apoptosis through the generation of reactive oxygen species 2004 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Brian K. Rundall, Dylan Jones	12
9	Combined histone deacetylase and NF-κB inhibition sensitizes non-small cell lung cancer to cell death 2004 ·Surgery ·Brian K. Rundall, Chadrick E. Denlinger, David R. Jones	51
10	Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-κB 2004 ·Seminars in Thoracic and Cardiovascular Surgery ·Chadrick E. Denlinger, Brian K. Rundall, David R. Jones	52
11	Efficacy of histone deacetylase inhibitors in NSCLC is attenuated by NF-kB acetylation 2004 ·Journal of the American College of Surgeons ·Brian K. Rundall, Chadrick E. Denlinger, David R. Jones	1
12	Proteasome Inhibition Sensitizes Non–Small-Cell Lung Cancer to Gemcitabine-Induced Apoptosis 2004 ·The Annals of Thoracic Surgery ·Chadrick E. Denlinger, Brian K. Rundall, Michael D. Keller, David R. Jones	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact